|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.74 CNY | +1.19% |
|
+5.39% | -51.33% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
| Capitalization | 71.19B 9.79B 9.33B 8.68B 7.74B 13.77B 830B 15.16B 108B 40.01B 340B 36.78B 35.96B 1,460B | P/E ratio 2024 * |
22.5x | P/E ratio 2025 * | 7.7x |
|---|---|---|---|---|---|
| Enterprise value | 65.02B 8.94B 8.52B 7.93B 7.07B 12.58B 758B 13.84B 98.44B 36.54B 310B 33.59B 32.84B 1,334B | EV / Sales 2024 * |
2.02x | EV / Sales 2025 * | 1.14x |
| Free-Float |
14.76% | Yield 2024 * |
0.97% | Yield 2025 * | 2.7% |
More valuation ratios
* Estimated data
More news
More news
| 1 day | +1.19% | ||
| 1 week | +5.39% | ||
| Current month | +1.19% | ||
| 1 month | +5.27% | ||
| 3 months | +29.02% | ||
| 6 months | -9.33% | ||
| Current year | -51.33% |
1 week
28.56
29.84
1 month
27.9234.28
Current year
20.3861.11
1 year
20.3867.04
3 years
20.3895.65
5 years
20.38154.13
10 years
5.35154.13
| Director | Title | Age | Since |
|---|---|---|---|
Zhen Jing Li
DFI | Director of Finance/CFO | 42 | 2015-08-18 |
Ren Sheng Jiang
PSD | President | 71 | 2009-08-16 |
Jie Xun
PRN | Corporate Officer/Principal | 35 | 2016-12-31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ren Sheng Jiang
CHM | Chairman | 71 | 2009-08-16 |
Ling Feng Jiang
BRD | Director/Board Member | 44 | 2018-08-09 |
Zhen Jing Li
BRD | Director/Board Member | 42 | 2018-04-09 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.58% | 12 M€ | -16.71% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +1.19% | +5.39% | -53.76% | -64.28% | 9.71B | ||
| +0.70% | +0.57% | +7.01% | -7.41% | 89B | ||
| -0.41% | +3.96% | +36.57% | +8.98% | 49.64B | ||
| +0.32% | +3.31% | +160.14% | +92.42% | 37.1B | ||
| +2.24% | +3.48% | -30.01% | -28.13% | 23.41B | ||
| -1.81% | -0.38% | +35.58% | +9.92% | 14.37B | ||
| -0.60% | -0.92% | +46.91% | -38.19% | 12.74B | ||
| -1.50% | -0.08% | -29.63% | -23.19% | 12.58B | ||
| +7.86% | +3.42% | +265.62% | +425.98% | 10.67B | ||
| +0.99% | +5.31% | +21.87% | +35.13% | 9.51B | ||
| Average | +0.90% | +2.66% | +46.03% | +41.12% | 26.87B | |
| Weighted average by Cap. | +0.60% | +2.81% | +40.69% | +22.99% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 32.2B 4.43B 4.22B 3.93B 3.5B 6.23B 375B 6.86B 48.75B 18.1B 154B 16.64B 16.26B 661B | 51.89B 7.14B 6.8B 6.33B 5.64B 10.04B 605B 11.05B 78.57B 29.16B 248B 26.81B 26.21B 1,064B |
| Net income | 3.31B 455M 434M 404M 360M 641M 38.59B 705M 5.01B 1.86B 15.81B 1.71B 1.67B 67.93B | 9.64B 1.33B 1.26B 1.18B 1.05B 1.87B 112B 2.05B 14.59B 5.42B 46.03B 4.98B 4.87B 198B |
| Net Debt | -6.17B -849M -809M -752M -671M -1.19B -71.92B -1.31B -9.34B -3.47B -29.47B -3.19B -3.12B -127B | -12.05B -1.66B -1.58B -1.47B -1.31B -2.33B -140B -2.57B -18.25B -6.77B -57.55B -6.23B -6.09B -247B |
More financial data
* Estimated data
Employees
6,545
Sector
Pharmaceuticals
Calendar
2025-04-28
- Q4 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-02 | 29.74 ¥ | +1.19% | 24,848,180 |
| 24-11-29 | 29.39 ¥ | +1.34% | 23,481,300 |
| 24-11-28 | 29.00 ¥ | -1.53% | 18,764,580 |
| 24-11-27 | 29.45 ¥ | +1.73% | 22,234,800 |
| 24-11-26 | 28.95 ¥ | -1.06% | 22,943,700 |
End-of-day quote Shenzhen S.E., December 01, 2024
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
29.74CNY
Average target price
36.76CNY
Spread / Average Target
+23.62%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300122 Stock